Practice
Featured experience
Comcast spinoff of select cable television networks
We are advising Comcast on the transaction
Durational Capital Management strategic investment in Garage Beer
We are advising Durational Capital Management on the transaction
Arcos Dorados renewal of long-term master franchise agreement with McDonald’s
We advised Arcos Dorados on the transaction
GSK strategic alliance with Vesalius Therapeutics
We advised GSK on the transaction
Davis Polk Advises Williams on Its Sale of Its 50% Interest in Jackalope Gas Gathering Services to an Affiliate of Crestwood Equity Partners
Davis Polk advised The Williams Companies, Inc. on its $484.6 million sale of a 50% interest in Jackalope Gas Gathering…
Williams sale of its 50% interest in Jackalope Gas Gathering Services
We advised Williams on the sale to an affiliate of Crestwood Equity Partners
Ferrero Group $1.3 billion acquisition of Kellogg cookies and fruit snacks businesses
Davis Polk is advising The Ferrero Group on its $1.3 billion acquisition of Kellogg Company’s cookie, fruit and fruit…
Davis Polk Advises S&P Global on Its Sale of SPIAS
Davis Polk is advising S&P Global Inc. on the sale of its subsidiary, Standard & Poor’s Investment Advisory Services…
Davis Polk Advises ShockWave Medical, Inc. on Its $111.4 Million Initial Public Offering
Davis Polk advised ShockWave Medical, Inc. on its SEC-registered initial public offering of 6,555,000 shares of common stock…
Horizon Pharma Follow-On Offering
Davis Polk advised the underwriters in connection with the $345 million public offering of ordinary shares of Horizon Pharma…
FMC completes spinoff of Livent
Davis Polk advised FMC Corporation in connection with the spinoff of its 123,000,000 shares of common stock of Livent…
Cornell Capital’s Corelle Brands to merge with Instant Brands
Davis Polk is advising Cornell Capital LLC on the merger of its portfolio company, Corelle Brands LLC, with Instant Brands,…
Davis Polk Advises Roche on Its Acquisition of Spark Therapeutics
Davis Polk is advising Roche on its approximately $4.3 billion acquisition of Spark Therapeutics, Inc. The transaction,…
Pernix Enters into an Agreement for the Sale of Substantially All of Its Assets Subject to a Competitive Bidding Process and Files for Chapter 11
Davis Polk is advising Pernix Therapeutics Holdings, Inc. in connection with its restructuring under chapter 11 of the…